CDEK by Data4ThePeople

Sign in Sign up

← All organizations

UniQure N.V.

For profitWebsite ↗

Also known as: UniQure Biopharma B.V. | uniQure France SAS

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 5, 2024

Timeline

1990s

Jan 1, 1998
UniQure N.V.— Founded

2010s

Feb 17, 2012
Amsterdam Molecular Therapeutics— Acquired

2020s

Jun 22, 2021
Corlieve Therapeutics— Acquired

Drugs by trial phase (13 distinct, 13 trials)

Phase 3 (1 own, 4 via acquisition)

Phase 2 (7 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

raav2/5-pbgd

Indications

Studied for

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (14)

NCT06270316Lead sponsorPhase 1/Phase 2Jun 5, 2024
NCT06100276Lead sponsorPhase 1/Phase 2Feb 1, 2024
NCT06063850Study directorPhase 1/Phase 2Nov 17, 2023
NCT06063850Lead sponsorPhase 1/Phase 2Nov 17, 2023
NCT05243017Overall official - principal investigatorPhase 1/Phase 2Oct 7, 2021
NCT05243017Lead sponsorPhase 1/Phase 2Oct 7, 2021
NCT04120493Lead sponsorPhase 1/Phase 2Oct 31, 2019
NCT03489291Lead sponsorPhase 2Jul 24, 2018
NCT03569891Lead sponsorPhase 3Jun 27, 2018
NCT02904772Lead sponsorPhase 2Oct 1, 2016
NCT02396342Lead sponsorPhase 1/Phase 2May 1, 2015
NCT02396342Study directorPhase 1/Phase 2May 1, 2015
NCT03300453Lead sponsorPhase 1/Phase 2Sep 30, 2013
NCT02082860CollaboratorPhase 1Nov 1, 2012

Details

Founded: Amsterdam, NL Jan 1, 1998
Last known activity: Jun 5, 2024